Kidney Cancer, Version 3.2015

Cancer statistics, 2014

2014 • 11,270 citations

Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial

2010 • 2,417 citations

Comparison of 1,800 Laparoscopic and Open Partial Nephrectomies for Single Renal Tumors

2007 • 1,158 citations

Axitinib versus sorafenib as first-line therapy in patients with metastatic renal-cell carcinoma: a randomised open-label phase 3 trial

2013 • 390 citations

Progression and Survival after Renal-Conserving Surgery for Renal Cell Carcinoma: Experience in 104 Patients and Extended Followup

1990 • 332 citations

Axitinib with or without dose titration for first-line metastatic renal-cell carcinoma: a randomised double-blind phase 2 trial

2013 • 224 citations

Evaluation of the National Comprehensive Cancer Network and American Urological Association Renal Cell Carcinoma Surveillance Guidelines

2014 • 141 citations

495: Comparison of 1800 Laparoscopic and Open Partial Nephrectomies for Single Renal Tumors

2007 • 119 citations

Clinical Characteristics and Outcomes of Patients With Recurrence 5 Years After Nephrectomy for Localized Renal Cell Carcinoma

2010 • 87 citations

Partial nephrectomy for incidental renal cell carcinoma

1994 • 68 citations

Pazopanib as Second-Line Treatment After Sunitinib or Bevacizumab in Patients With Advanced Renal Cell Carcinoma: A Sarah Cannon Oncology Research Consortium Phase II Trial

2013 • 45 citations

Outcomes of patients with metastatic clear-cell renal cell carcinoma treated with pazopanib after disease progression with other targeted therapies

2013 • 40 citations

Comparison of radiographical imaging modalities for measuring the diameter of renal masses: is there a sizeable difference?

2011 • 20 citations